EPCAM and head and neck squamous cell carcinoma: Another group enriched for CTCs from the peripheral blood of advanced HNSCC based on the cell surface expression of EpCAM; here, CTCs were detected in 27% of evaluable patients but had no association with PFS or overall survival (OS) [63].